(Q33908873)

29 July 2017

1 reference

title

Vaccines for preventing cholera (English)

1 reference

29 July 2017

0 references

P Graves

1

0 references

author name string

J Deeks

2

1 reference

29 July 2017

V Demicheli

3

1 reference

29 July 2017

M Pratt

4

1 reference

29 July 2017

T Jefferson

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2000

0 references

published in

1 reference

29 July 2017

CD000974

1 reference

29 July 2017

2

1 reference

B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.

29 July 2017

4

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Field trial of oral cholera vaccines in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Immunogenicity of two formulations of oral cholera vaccines in Thai volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Five-year immunologic memory in Swedish volunteers after oral cholera vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

The quest for trials on the efficacy of human vaccines. Results of the handsearch of Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Field Trial of Oral Cholera Vaccines in Bangladesh: Results of One Year of Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Intestinal secretory antibody response induced by an oral cholera vaccine in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

Evaluating new vaccines for developing countries. Efficacy or effectiveness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000974

The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests.

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/INFDIS/121.SUPPLEMENT.S1

Identifiers

DOI

10.1002/14651858.CD000974

1 reference

29 July 2017

1 reference